Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
57
OXBDF Quote, Financials, Valuation and Earnings
Last price:
$11.34
Seasonality move
:
4.62%
Day range:
$11.34 - $11.34
52-week range:
$3.15 - $12.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.15x
P/B ratio:
9.28x
Volume:
43.2K
Avg. volume:
3.2K
1-year change:
126.85%
Market cap:
$1.4B
Revenue:
$164.6M
EPS (TTM):
-$0.47
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Oxford Biomedica Plc has -- downside to fair value with a price target of -- per share.
OXBDF vs. S&P 500
-
Over the past 5 trading days, Oxford Biomedica Plc has underperformed the S&P 500 by -1.26% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Oxford Biomedica Plc does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Oxford Biomedica Plc has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Oxford Biomedica Plc reported revenues of --.
Earnings Growth
-
Oxford Biomedica Plc has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Oxford Biomedica Plc reported earnings per share of --.
Enterprise value:
642.6M
EV / Invested capital:
--
Price / LTM sales:
6.15x
EV / EBIT:
--
EV / Revenue:
3.92x
PEG ratio (5yr expected):
-6.30x
EV / Free cash flow:
-8.73x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$85.9M
Return On Assets:
-46.7%
Net Income Margin (TTM):
-25.87%
Return On Equity:
-120.93%
Return On Invested Capital:
-90.47%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2017-12-31 | 2018-12-31 | |
| Income Statement | ||||||
| Revenue | $36.9M | $49.1M | $88.6M | -- | -- | |
| Gross Profit | $21.3M | $25M | $45M | -- | -- | |
| Operating Income | -$15.4M | -$10.4M | $10.9M | -- | -- | |
| EBITDA | -$15.6M | $2.7M | $20.9M | -- | -- | |
| Diluted EPS | -$0.41 | -$0.19 | $0.15 | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $171.5M | $246.1M | $224.1M | $175.7M | -- | |
| Total Assets | $273.6M | $566.1M | $505.9M | $309.8M | -- | |
| Current Liabilities | $65.4M | $134.4M | $67.5M | $74.8M | -- | |
| Total Liabilities | $90.1M | $250.7M | $255.9M | $219.8M | -- | |
| Total Equity | $183.5M | $315.4M | $249.9M | $90.1M | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-02-13 | 2025-02-13 | 2025-02-13 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
OXBDF
Sector
Market Cap
$1.4B
$23.4M
Price % of 52-Week High
89.95%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
-0.28%
-1.64%
1-Year Price Total Return
126.85%
-21.81%
Beta (5-Year)
1.082
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$11.33
200-day SMA
Buy
Level
$7.15
Bollinger Bands (100)
Buy
Level
7.59 - 10.57
Chaikin Money Flow
Sell
Level
-790
20-day SMA
Sell
Level
$11.88
Relative Strength Index (RSI14)
Buy
Level
58.27
ADX Line
Sell
Level
48.31
Williams %R
Neutral
Level
-77.5
50-day SMA
Buy
Level
$9.92
MACD (12, 26)
Buy
Level
3.10
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
43.7K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.4946)
Sell
CA Score
(Annual)
Level (-2.1791)
Sell
Beneish M-Score
(Annual)
Level (-1.1594)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (4.3218)
Sell
Piotroski F Score
(Annual)
Level (3)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The firm also provides bioprocessing and process development services to third parties. The company was founded by Alan J. Kingsman and Susan M. Kingsman in 1995 and is headquartered in Oxford, the United Kingdom.
Stock Forecast FAQ
In the current month, OXBDF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OXBDF average analyst price target in the past 3 months is --.
-
Where Will Oxford Biomedica Plc Stock Be In 1 Year?
According to analysts, the consensus estimate is that Oxford Biomedica Plc share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Oxford Biomedica Plc?
Analysts are divided on their view about Oxford Biomedica Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Oxford Biomedica Plc is a Sell and believe this share price will rise from its current level to --.
-
What Is Oxford Biomedica Plc's Price Target?
The price target for Oxford Biomedica Plc over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OXBDF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Oxford Biomedica Plc is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of OXBDF?
You can purchase shares of Oxford Biomedica Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Oxford Biomedica Plc shares.
-
What Is The Oxford Biomedica Plc Share Price Today?
Oxford Biomedica Plc was last trading at $11.34 per share. This represents the most recent stock quote for Oxford Biomedica Plc. Yesterday, Oxford Biomedica Plc closed at $11.34 per share.
-
How To Buy Oxford Biomedica Plc Stock Online?
In order to purchase Oxford Biomedica Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get OXBDF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OXBDF
Sector
P/E ratio
--
23.34x
PEG ratio
-6.30x
-0.01x
P/B ratio
9.28x
1.72x
Price / LTM sales
6.15x
1.51x
Growth Metrics
OXBDF
Sector
Revenue growth
--
3.21%
Earnings growth
--
10.12%
Revenue (5-year growth)
15.03%
6.27%
Earnings forecast
--
-$0.19
Profitability
OXBDF
Sector
Profitability FY 2024
$66.9M
$2.7M
Return on invested capital
-90.47%
-33.62%
Return on assets
-46.7%
-29.68%
Return on equity
-120.93%
-38.89%
Earnings Date
Last Earnings Date
Sep
23
Next Earnings Date
Apr
9
Estimated Next Earnings Date
Dec
23
Balance Sheet
OXBDF
Sector
Total cash
$103M
$25M
Short term investments
--
$23.9M
Total assets
$290.1M
$72.8M
Long term debt
--
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.64% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
